Susan Hasty, Publisher
Table of Contents . . . September 21st, 1998Non-Subscriber - Summaries Only
Cancer Immunotherapy - Study Suggests Genetic Immunotherapy Possible for Colorectal Cancer
Antiangiogenesis Gene Therapy - Tek Explored for Anticancer Therapeutic Potential
Cancer Gene Therapy - Bicistronic Triple Gene Vector Provides New Immuno/Suicide Gene Therapy Tool
Cancer Immunotherapy - Pulsed Murine Dendritic Cells Mediated Antitumor Immune Responses
Long-Term Transfection (Keratinocytes) - Optimized Retroviral Infection Facilitates Long-Term Gene Expression
Antisense Technology - Painless PNA Therapeutics
Antisense Therapy - Treatment Prevents Burkitt's Lymphoma In Mice
Breast Cancer - Test Approval Recommended To Select Patients for Cancer Drug
Breast Cancer - U.S. Panel Recommends Approval of Cancer Drugs
Colon Cancer - U.S. Scientists Say Two Cancer-Causing Genes Related
Drug Development - Cloning Could Create Life-Saving Drugs Faster
Gastrointestinal Disorders - ALX-0600 Drug Enters Clinical Trials
Industry News (Patents and Technologies) - U.S. Patent on p16 Tumor Suppressor Gene Awarded
Risk Factors (Bladder Cancer) - Gene Environmental Exposure Interaction Shown to Escalate Smoking-Related Cancer
Pathogenesis (HBV) - "Hepatitis B Virus X Protein Interacts With NF-KB Inhibitors."
Gene Transfer - "Transient Inhibition of CD28 and CD40 Ligand Interactions Prolongs Adenovirus-Mediated Transgene Expression in the Lung and Facilitates Expression after Secondary Vector Administration."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.